Canada - TSX-V:GENX - CA37232A1093 - Common Stock
The current stock price of GENX.CA is 0.03 CAD. In the past month the price decreased by -14.29%. In the past year, price decreased by -25%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| JWEL.CA | JAMIESON WELLNESS INC | 22.02 | 1.48B | ||
| LOVE.CA | CANNARA BIOTECH INC | 9.53 | 153.74M | ||
| VPI.CA | VITALITY PRODUCTS INC | N/A | 1.24M | ||
| HILL.CA | HILL STREET BEVERAGE CO INC | N/A | 557.60K |
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm is a formulator, manufacturer, licensor and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its operations consist primarily of the research, development, manufacture, in-licensing and sales of novel and healthcare products, focusing on proprietary over the counter (OTC) nutraceuticals and generic pharmaceuticals. The firm has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and others.
GENIX PHARMACEUTICALS CORP
Suite 300, 1055 West Hastings St
Vancouver BRITISH COLUMBIA V6E 1J8 CA
CEO: Sina Salehi Pirooz
Employees: 0
Phone: 16046096198
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm is a formulator, manufacturer, licensor and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its operations consist primarily of the research, development, manufacture, in-licensing and sales of novel and healthcare products, focusing on proprietary over the counter (OTC) nutraceuticals and generic pharmaceuticals. The firm has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and others.
The current stock price of GENX.CA is 0.03 CAD.
GENX.CA does not pay a dividend.
GENX.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
GENIX PHARMACEUTICALS CORP (GENX.CA) operates in the Consumer Staples sector and the Personal Care Products industry.
GENIX PHARMACEUTICALS CORP (GENX.CA) currently has 0 employees.
GENIX PHARMACEUTICALS CORP (GENX.CA) has a market capitalization of 1.84M CAD. This makes GENX.CA a Nano Cap stock.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -327.68% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |